Meridian Medica — Asian Ginseng

01

Identity

Botanical Profile

Panax ginseng C.A.Mey. — Root (dried; white ginseng = dried root; red ginseng = steamed and dried root). Native to northeastern China (Manchuria), Korean Peninsula, and far eastern Russia (Primorsky Krai); historically harvested wild; now almost exclusively cultivated in Korea, China, and Russia due to near-extinction of wild populations

Root: distinctly bitter-sweet with earthy, warm undertones; slight pungency. White ginseng (dried): pale tan-yellow, wrinkled surface, dense texture. Red ginseng (steamed): dark reddish-brown, glossy, harder texture, more potent and warming. Aroma: earthy, slightly medicinal, warm. Taste: initially bitter then sweet, with slight pungency and warming sensation. Higher ginsenoside content generally correlates with more bitter taste.

Species Integrity

Panax ginseng is one of the most adulterated herbs in commerce. The genus Panax includes P. ginseng (Asian), P. quinquefolius (American, more cooling and yin-tonifying), and P. notoginseng (notoginseng/san qi, primarily used for hemostasis). These are pharmacologically distinct and not interchangeable. Additionally, Siberian ginseng (Eleutherococcus senticosus) and Brazilian ginseng (Suma/Pfaffia paniculata) are not true Panax species and have different chemistry despite being called 'ginseng'.

02

Compounds

Active Compound Profile

Ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rg1, Rg2, Rh1, Rh2)

2–6% total ginsenosides in quality root; red ginseng: higher Rg-series; white ginseng: higher Rb-series

Steroidal saponin glycosides with multiple mechanisms: PPAR-γ activation (Rb1); HPA axis modulation (Rg1); AMPK activation; NO production enhancement; neuroprotective via BDNF; anti-inflammatory via NF-κB; immunomodulatory (bidirectional); phytoestrogenic (ERβ)

Compound K (20-O-beta-(D-glucopyranosyl)-20(S)-protopanaxadiol)

Primary metabolite produced by gut bacteria from Rb1/Rb2; directly present in red ginseng after processing

Most bioavailable active ginsenoside metabolite; AMPK activator; anti-inflammatory; anti-cancer; insulin sensitizer; directly absorbed from intestine

Gintonin (lysophosphatidic acid-containing glycolipoprotein)

Present in ginseng root; separate from ginsenoside fraction

LPA receptor agonist; neuroprotective; anxiolytic via LPA1/LPA2 receptor signaling; distinct from ginsenoside mechanisms

Panaxans (polysaccharides)

5–15% root dry weight

Immunomodulatory via macrophage and NK cell activation; hypoglycemic activity via insulin secretion stimulation; prebiotic substrate

Acetylenic compounds (panaxydol, panaxynol)

Trace amounts

Antimicrobial; anti-cancer; anti-inflammatory

Absorption

Red ginseng over white ginseng for bioavailability: Steam processing partially metabolizes Rb-series ginsenosides toward compound K and other more bioavailable forms; red ginseng provides higher direct compound K content without requiring gut microbiome conversion

03

Pathways

Mechanism of Action

★★★☆☆ HPA Axis Modulation / Adaptogenic Mechanism Ginsenoside Rg1 modulates CRH release from hypothalamus and ACTH release from pituitary; prevents cortisol overshoot under stress while supporting appropriate cortisol release; normalizes HPA axis through bidirectional regulation

★★★☆☆ AMPK / Metabolic Activation Compound K and ginsenoside Rg1 activate AMPK in muscle and adipose; improve insulin sensitivity; promote glucose uptake in skeletal muscle; reduce hepatic glucose output

★★★☆☆ NF-κB / Inflammatory Cytokine Suppression Multiple ginsenosides inhibit NF-κB nuclear translocation; reduce TNF-α, IL-6, IL-1β; Rh2 shows particularly potent NF-κB inhibition; complementary anti-inflammatory to many other Meridian Medica herbs

★★★☆☆ Immune Bidirectional Modulation Panaxans activate macrophages and NK cells (immune stimulating); ginsenosides can suppress T cell overactivation (immune dampening); the net effect is immune normalization rather than simple stimulation or suppression

★★★☆☆ Nitric Oxide Synthesis / Vascular Function Ginsenoside Re and others upregulate eNOS activity; increase NO bioavailability; improve endothelial-dependent vasodilation; support cardiovascular function and peripheral circulation

★★★☆☆ Neuroprotective / Cognitive Enhancement Multiple pathways: BDNF upregulation (Rb1); acetylcholinesterase inhibition (Rg1); NMDA receptor modulation; antioxidant protection of neurons; gintonin LPA receptor neuroprotection

04

Biomarkers

What It Moves in Your Labs

Biomarker	Direction	Target	Mechanism
Fasting Glucose	↓ Decrease	<100 mg/dL	AMPK activation and compound K-mediated insulin sensitization reduce hepatic glucose output and improve peripheral glucose uptake
Fasting Insulin	↓ Decrease	<7 uIU/mL	Improved insulin sensitivity reduces compensatory hyperinsulinemia; direct insulin secretion modulation by panaxans
Cortisol (AM serum)	Normalize (↓ if elevated, ↑ if insufficient)	10–18 mcg/dL serum (morning); bidirectional normalization	HPA axis adaptogenic bidirectional regulation via Rg1; prevents both cortisol excess and cortisol insufficiency
hs-CRP	↓ Decrease	<1.0 mg/L	NF-κB inhibition by multiple ginsenosides; systemic anti-inflammatory effect
TPO Antibodies	↓ Decrease	<35 IU/mL	Immune normalization (bidirectional); reduced autoimmune inflammatory burden via NF-κB suppression and T-cell regulation

05

Extraction

Extraction & Preparation

Korean red ginseng root slices (decoction): Full ginsenoside spectrum; high compound K; gintonin; panaxans

Solubility · Water-soluble as glycosides; enhanced solubility in hot water; also ethanol-solubleMenstruum · 70% ethanolPlant material · Dried Korean red ginseng root, sliced or powdered (6-year root preferred)Maceration time · 4–6 weeks (agitate daily)Ratio · 1:5 (dried)

07

Dosing

Dosing Framework

Morning use preferred: take ginseng preparations with or just before breakfast; aligns with natural cortisol morning peak and amplifies the day's energy; avoids evening use that may interfere with sleep onset in sensitive individuals.

Dose 1

Standardized extract: 200–400mg (5–7% ginsenosides), 1–2x daily

Most clinically studied range; Korean Pharmacopoeia standard; morning dosing preferred

Dose 2

Whole root equivalent: 1–2g dried root daily

Traditional East Asian dosing range; consistent with clinical trial parameters

Dose 3

Tincture: 2–4 mL (1:5, 70% ethanol), 1–2x daily

Standard liquid extract dose; morning use; combine with other adaptogenic tinctures

08

Synergies

Synergy Partners

★★★☆☆ Astragalus (Astragalus membranaceus) Classical TCM combination (Four Gentlemen basis): astragalus polysaccharides modulate innate immunity and NK cells; ginseng ginsenosides modulate adaptive immunity and HPA; combined provides bidirectional immune normalization plus adaptogenic HPA support

★★★☆☆ Eleuthero / Siberian Ginseng (Eleutherococcus senticosus) Eleutherosides complement ginsenosides at different receptor pathways; eleuthero is gentler and more cooling; combined provides broader adaptogenic spectrum while reducing overstimulation risk

★★★☆☆ Rhodiola (Rhodiola rosea) Rosavin and salidroside (Rhodiola) + ginsenosides (ginseng) = synergistic HPA modulation through different mechanisms; Rhodiola particularly addresses fatigue and exercise recovery; ginseng addresses broader metabolic and immune adaptation

★★★☆☆ Black Pepper (Piper nigrum) Piperine inhibits CYP3A4-mediated ginsenoside metabolism; extends ginsenoside half-life and enhances overall bioavailability by 30–40%; direct bioavailability enhancement

Signature Stack

THE TRIPLE ADAPTOGEN STACK
Components: Asian Ginseng (Panax ginseng) + Rhodiola (Rhodiola rosea) + Eleuthero (Eleutherococcus senticosus) · Multi-pathway convergence: HPA axis normalization via three distinct mechanisms (ginsenoside CRH modulation + rosavin DAT/NET inhibition + eleutheroside cortisol buffering) + AMPK metabolic activation (ginseng + rhodiola) + immune bidirectional modulation (ginseng + eleuthero) + mitochondrial biogenesis support (all three) · This stack represents the most comprehensive botanical approach to chronic HPA axis dysregulation — the central upstream driver of both Hashimoto's autoimmune activation and hypothyroid metabolic depression. No single adaptogen covers all three HPA pathways simultaneously. · Practical integration: Morning decoction (ginseng + eleuthero), with midday Rhodiola capsule if fatigued. Cycle all three together for 3 months, then 1 month with gentler herbs (ashwagandha, lemon balm, holy basil) before repeating.

09

Safety

Contraindications & Interactions

Avoid Pregnancy Ginsenoside Rb1 has shown teratogenic effects in some animal studies; ginseng stimulates uterine contractions at high doses in animal models. Traditional use across Asia during pregnancy at low food-level doses exists, but clinical safety data is insufficient.

Minor Estrogen-sensitive conditions Ginsenosides have phytoestrogenic activity (ERβ agonism); may stimulate estrogen-responsive tissue growth. Theoretical concern for estrogen-receptor-positive cancers and conditions exacerbated by estrogen (endometriosis, fibroids).

Minor Hypertension and cardiovascular stimulation High-dose ginseng can increase blood pressure; ginsenosides have bidirectional effects — low dose vasodilatory via NO, high dose vasoconstrictive. 'Ginseng abuse syndrome' at very high chronic doses includes hypertension, insomnia, and agitation.

Minor Insomnia and stimulation Panax ginseng is warming and stimulating; evening use may cause or worsen insomnia, particularly in yin-deficient or heat-presenting patients.

Minor Warfarin / anticoagulant interaction Ginsenosides have mild antiplatelet and anticoagulant activity; may potentiate warfarin effect. Case reports of INR changes with ginseng supplementation.

11

Evidence

Evidence Base

★★★★☆ Adaptogenic Stress Modulation / Fatigue Strong — Multiple RCTs; systematic reviews; extensive traditional clinical record

★★★★☆ Cognitive Enhancement Strong — Multiple double-blind crossover RCTs; systematic reviews

★★★★☆ Glycemic Control / Insulin Sensitivity Strong — Multiple RCTs including gold-standard design; consistent across species

★★★☆☆ Immune Modulation Moderate — Multiple RCTs for infection prevention; bidirectional immune effects

★★★☆☆ Erectile Dysfunction / Sexual Function Moderate — Multiple RCTs; NO-mediated mechanism well-supported

Evidence Gaps

The highest-value research gap for Meridian Medica: no published RCT has evaluated Panax ginseng specifically in Hashimoto's thyroiditis for TPO antibody reduction. Given ginseng's bidirectional immune modulation (preventing both hyper- and hypo-immune states), AMPK-driven metabolic support, and HPA axis normalization — all directly relevant to Hashimoto's pathology — a 6-month RCT with Korean red ginseng in Hashimoto's women measuring TPO antibodies, TSH, free T3, cortisol, and metabolic markers would be a landmark contribution to integrative thyroid medicine.

Quality Alert

Asian ginseng is one of the most frequently adulterated herbs in commerce. Key adulteration vectors:

12

Protocol

Protocol Integration

Layer 1: Hypothalamic / Autonomic — HPA axis, circadian rhythm, stress response

Layer 2: Systemic Nutritional Repletion — Micronutrient optimization, antioxidant defense

Layer 3: Gut Permeability / Microbiome — Tight junction repair, motility, SIBO management

Recipe Integration

Morning Adaptogen Decoction (signature preparation)

3–5 red ginseng slices daily; full decoction volume consumed in morning

Feed the Markers

Asian Ginseng appears in the following Meridian Medica protocol contexts: